Humalog 75/25 Usage and Dosing Guidelines for Diabetes

Introduction to Humalog 75/25

The American Diabetes Association recommends Humalog 75/25 (insulin lispro protamine/insulin lispro) to be administered twice daily, 5-15 minutes before breakfast and dinner, with typical starting doses of 0.3-0.5 units/kg/day divided between morning and evening doses for patients with type 1 or type 2 diabetes 1, 2

For insulin-naïve patients, the American Association of Clinical Endocrinologists suggests starting with 0.3-0.5 units/kg/day divided into two doses 3, 2
For patients with higher risk of hypoglycemia, such as the elderly or those with renal impairment, the Endocrine Society recommends using lower starting doses 3, 2
For patients already on insulin therapy, the American College of Endocrinology advises maintaining the same total daily dose initially when switching to Humalog 75/25, but adjusting the distribution to approximately 2/3 before breakfast and 1/3 before dinner 1

The American Diabetes Association recommends more frequent blood glucose monitoring during initiation or transition to Humalog 75/25, particularly focusing on both fasting and postprandial glucose levels 1, 2
The Endocrine Society suggests adjusting doses based on pre-dinner and bedtime glucose for evening dose 2
Target fasting glucose values should be within the normal range according to individualized goals, as recommended by the American Association of Clinical Endocrinologists 1
If hypoglycemia occurs, the American College of Endocrinology recommends reducing the dose by 10-20% 1

The American College of Physicians notes that basal-bolus insulin regimens provide more flexibility but require more injections than premixed formulations 4, 3
For patients with type 2 diabetes who fail to achieve glycemic targets on basal insulin alone, the American Diabetes Association recommends adding a premixed insulin like Humalog 75/25 to improve control 4, 2
The Endocrine Society advises that premixed insulin therapy has been associated with higher rates of hypoglycemia in hospitalized patients and is not recommended in the hospital setting 5, 3

The American Association of Clinical Endocrinologists emphasizes the importance of consistent meal timing with premixed insulin regimens to avoid hypoglycemia 1, 6
The American College of Endocrinology recommends that Humalog 75/25 should not be mixed with other insulins in the same syringe 6

The Endocrine Society warns against mixing Humalog 75/25 with other insulins, especially glargine, in the same syringe 6
The American College of Physicians advises avoiding the use of premixed insulin formulations in hospitalized patients due to higher risk of hypoglycemia 5, 3
The American Diabetes Association recommends not using the same dose for both morning and evening injections; the morning dose should typically be higher than the evening dose 1
The American Association of Clinical Endocrinologists emphasizes the importance of monitoring during transition periods between insulin regimens, as this is when hypoglycemia risk is highest 1, 2